Daehan New Pharm Co., Ltd. manufactures and sells pharmaceuticals and animal health products primarily in South Korea. The company offers hepatic protectors, osteoporosis, urinary reproductive substances, digestive substances, mental nerve substances, respiratory substances, infections therapeutics, muscle relaxants, circulatory substances, antispasmodics, antihistamines, and antipyretic analgesic and anti-inflammatory products; and products for the treatment of diabetes and obesity. It also provides animal health products, including metabolic stimulants, disinfectants, antibiotic antimicrobial products, coccidiosis repellents, and bot gujeje products. In addition, the company offers herbals, health foods, and functional beverages. It exports anticancer drugs, antibiotics, thrombolytics, vasodilators, antihistamins, and antidiabetics primarily to Southeast Asia, Latin America, and Africa; and supplies animal feed to Pakistan. The company offers its products in various forms comprising tablets, capsules, granules, powder, creams, ointments, gels, unguents, vials, and ampoules. Daehan New Pharm Co., Ltd. was founded in 1984 and is based in Hwaseong, South Korea.
daehan new pharm co ltd (054670:KOSDAQ)
66, Jeyakgongdan 1-gil
Phone: 82 3 1353 6141
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for 054670.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact DAEHAN NEW PHARM CO LTD, please visit www.dhnp.co.kr/eng/default.htm. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.